Pfizer has urged the U.S. to approve its new experimental COVID-19 pills that can be taken at home to prevent a rising number of virus patients in hospital this winter.
A Food and Drugs Administration (FDA) panel is due to meet this Friday to consider approving booster shots for all American adults, with some states already making the move ahead of the decision, but Pfizer is hopeful the group will make a decision on its experimental COVID drug before then.
Meanwhile, lockdowns have been announced in several countries that target the unvaccinated to reduce the impact of an expected new wave of infections over Christmas and New Year. Infections have been rapidly rising across Europe in recent weeks.
